While the market weakness we have experienced this week is disappointing, I believe it is an opportunity for investors to buy shares at more attractive prices.
Two ASX shares which have pulled back notably this week are listed below. Here’s why I would buy them:
Bravura Solutions Ltd (ASX: BVS)
The Bravura Solutions share price has fallen over 8% this week. This means its shares are now trading almost 27% below their 52-week high. I think this is a buying opportunity for long-term focused investors. Especially given Bravura’s strong growth potential and attractive valuation.
Bravura is provider of software products and services to financial institutions. These include major institutions such as BNP Paribas, Fidelity, and Mercer. Arguably the key product in its portfolio is the Sonata wealth management platform. This high quality platform allows its users to connect and engage with their clients anytime, anywhere, through computers, tablets, or smartphones. It also simplifies legacy client systems into one unified customer-centric solution.
Combined with recent acquisitions, which have opened it up to new and lucrative markets, I believe the future is very bright for this growing company.
Nanosonics Ltd (ASX: NAN)
The Nanosonics share price is down over 11% since this time last week. I think this is an opportunity for investors to buy the shares of one of the most promising healthcare companies at a fairer price.
I’m a big fan of the infection prevention company due to the strong growth potential of its trophon EPR product and the upcoming launch of new products targeting unmet needs. In respect to the former, the trophon EPR disinfection system for ultrasound probes is regarded as the best in its class. At the end of the first half its installed base stood at 22,500. This represents just under 19% of its global market opportunity. I believe this footprint can grow materially in the future and drive strong unit sales and recurring revenues from the consumables it requires.
Furthermore, the company has revealed that the secretive new products it has under development have similar market opportunities. In light of this, I think Nanosonics is in a fantastic position to deliver strong sales and earnings growth over the next decade.
And here are more exciting shares which could be stars of the future…
One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.
Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
More reading
- 2 red hot ASX growth shares
- Where to invest $500 into ASX shares right now
- 3 ASX 200 shares to protect your portfolio from recession
- Why I’d buy Appen and these ASX growth shares for the 2020s
- Could these ASX shares be the future dividend stars that make you rich?
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Bravura Solutions Ltd and Nanosonics Limited. The Motley Fool Australia has recommended Bravura Solutions Ltd and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post 2 outstanding ASX shares to buy after the market crash appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3fhBEgm
Leave a Reply